List of Tables
Table 1. Global Platinum-based Anticancer Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Platinum-based Anticancer Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Platinum-based Anticancer Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Platinum-based Anticancer Drugs Sales (MT) of Key Manufacturers (2020-2025)
Table 5. Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Platinum-based Anticancer Drugs Average Price (US$/MT) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Platinum-based Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Platinum-based Anticancer Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Platinum-based Anticancer Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Platinum-based Anticancer Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Platinum-based Anticancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum-based Anticancer Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Platinum-based Anticancer Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Platinum-based Anticancer Drugs Sales by Region (2020-2025) & (MT)
Table 18. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Platinum-based Anticancer Drugs Sales by Region (2026-2031) & (MT)
Table 20. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Platinum-based Anticancer Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Platinum-based Anticancer Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Platinum-based Anticancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Platinum-based Anticancer Drugs Sales by Country (2020-2025) & (MT)
Table 27. North America Platinum-based Anticancer Drugs Sales by Country (2026-2031) & (MT)
Table 28. North America Platinum-based Anticancer Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Platinum-based Anticancer Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Platinum-based Anticancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Platinum-based Anticancer Drugs Sales by Country (2020-2025) & (MT)
Table 32. Europe Platinum-based Anticancer Drugs Sales by Country (2026-2031) & (MT)
Table 33. Europe Platinum-based Anticancer Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Platinum-based Anticancer Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Platinum-based Anticancer Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Platinum-based Anticancer Drugs Sales by Region (2020-2025) & (MT)
Table 37. Asia Pacific Platinum-based Anticancer Drugs Sales by Region (2026-2031) & (MT)
Table 38. Asia Pacific Platinum-based Anticancer Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Platinum-based Anticancer Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Platinum-based Anticancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Platinum-based Anticancer Drugs Sales by Country (2020-2025) & (MT)
Table 42. Latin America Platinum-based Anticancer Drugs Sales by Country (2026-2031) & (MT)
Table 43. Latin America Platinum-based Anticancer Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Platinum-based Anticancer Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2020-2025) & (MT)
Table 47. Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2026-2031) & (MT)
Table 48. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Platinum-based Anticancer Drugs Sales (MT) by Type (2020-2025)
Table 51. Global Platinum-based Anticancer Drugs Sales (MT) by Type (2026-2031)
Table 52. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Platinum-based Anticancer Drugs Price (US$/MT) by Type (2020-2025)
Table 59. Global Platinum-based Anticancer Drugs Price (US$/MT) by Type (2026-2031)
Table 60. Global Platinum-based Anticancer Drugs Sales (MT) by Application (2020-2025)
Table 61. Global Platinum-based Anticancer Drugs Sales (MT) by Application (2026-2031)
Table 62. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Platinum-based Anticancer Drugs Price (US$/MT) by Application (2020-2025)
Table 69. Global Platinum-based Anticancer Drugs Price (US$/MT) by Application (2026-2031)
Table 70. Sanofi-Aventis Company Information
Table 71. Sanofi-Aventis Description and Business Overview
Table 72. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 73. Sanofi-Aventis Platinum-based Anticancer Drugs Product
Table 74. Sanofi-Aventis Recent Developments/Updates
Table 75. Yakult honsha Company Information
Table 76. Yakult honsha Description and Business Overview
Table 77. Yakult honsha Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 78. Yakult honsha Platinum-based Anticancer Drugs Product
Table 79. Yakult honsha Recent Developments/Updates
Table 80. Dr Reddy's laboratories Company Information
Table 81. Dr Reddy's laboratories Description and Business Overview
Table 82. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 83. Dr Reddy's laboratories Platinum-based Anticancer Drugs Product
Table 84. Dr Reddy's laboratories Recent Developments/Updates
Table 85. Sun Pharmaceutical Company Information
Table 86. Sun Pharmaceutical Description and Business Overview
Table 87. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 88. Sun Pharmaceutical Platinum-based Anticancer Drugs Product
Table 89. Sun Pharmaceutical Recent Developments/Updates
Table 90. Teva Company Information
Table 91. Teva Description and Business Overview
Table 92. Teva Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 93. Teva Platinum-based Anticancer Drugs Product
Table 94. Teva Recent Developments/Updates
Table 95. Fresenius Kabi Company Information
Table 96. Fresenius Kabi Description and Business Overview
Table 97. Fresenius Kabi Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 98. Fresenius Kabi Platinum-based Anticancer Drugs Product
Table 99. Fresenius Kabi Recent Developments/Updates
Table 100. Hospira(Pfizer) Company Information
Table 101. Hospira(Pfizer) Description and Business Overview
Table 102. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 103. Hospira(Pfizer) Platinum-based Anticancer Drugs Product
Table 104. Hospira(Pfizer) Recent Developments/Updates
Table 105. Mylan Company Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 108. Mylan Platinum-based Anticancer Drugs Product
Table 109. Mylan Recent Developments/Updates
Table 110. Taj Pharmaceuticals Company Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 113. Taj Pharmaceuticals Platinum-based Anticancer Drugs Product
Table 114. Taj Pharmaceuticals Recent Developments/Updates
Table 115. Jiangsu Hengrui Medicine Company Information
Table 116. Jiangsu Hengrui Medicine Description and Business Overview
Table 117. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 118. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product
Table 119. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 120. Nanjing Pharmaceutical Factory Company Information
Table 121. Nanjing Pharmaceutical Factory Description and Business Overview
Table 122. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 123. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product
Table 124. Nanjing Pharmaceutical Factory Recent Developments/Updates
Table 125. Jiangsu Aosaikang Pharmaceutical Company Information
Table 126. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 127. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 128. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product
Table 129. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 130. Qilu Pharmaceutical Company Information
Table 131. Qilu Pharmaceutical Description and Business Overview
Table 132. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 133. Qilu Pharmaceutical Platinum-based Anticancer Drugs Product
Table 134. Qilu Pharmaceutical Recent Developments/Updates
Table 135. Hisun Pharmaceutical Company Information
Table 136. Hisun Pharmaceutical Description and Business Overview
Table 137. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 138. Hisun Pharmaceutical Platinum-based Anticancer Drugs Product
Table 139. Hisun Pharmaceutical Recent Developments/Updates
Table 140. Luoxin Company Information
Table 141. Luoxin Description and Business Overview
Table 142. Luoxin Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 143. Luoxin Platinum-based Anticancer Drugs Product
Table 144. Luoxin Recent Developments/Updates
Table 145. Lingnan Pharmacy Company Information
Table 146. Lingnan Pharmacy Description and Business Overview
Table 147. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 148. Lingnan Pharmacy Platinum-based Anticancer Drugs Product
Table 149. Lingnan Pharmacy Recent Developments/Updates
Table 150. Hansoh Pharma Company Information
Table 151. Hansoh Pharma Description and Business Overview
Table 152. Hansoh Pharma Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 153. Hansoh Pharma Platinum-based Anticancer Drugs Product
Table 154. Hansoh Pharma Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Platinum-based Anticancer Drugs Distributors List
Table 158. Platinum-based Anticancer Drugs Customers List
Table 159. Platinum-based Anticancer Drugs Market Trends
Table 160. Platinum-based Anticancer Drugs Market Drivers
Table 161. Platinum-based Anticancer Drugs Market Challenges
Table 162. Platinum-based Anticancer Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Platinum-based Anticancer Drugs
Figure 2. Global Platinum-based Anticancer Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Platinum-based Anticancer Drugs Market Share by Type: 2024 & 2031
Figure 4. Cisplatin Product Picture
Figure 5. Carboplatin Product Picture
Figure 6. Oxaliplatin Product Picture
Figure 7. Nedaplatin Product Picture
Figure 8. Others Product Picture
Figure 9. Global Platinum-based Anticancer Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Platinum-based Anticancer Drugs Market Share by Application: 2024 & 2031
Figure 11. Testicular Cancer
Figure 12. Osteosarcoma
Figure 13. Breast Cancer
Figure 14. Esophageal Cancer
Figure 15. NSCLC
Figure 16. Other
Figure 17. Global Platinum-based Anticancer Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Platinum-based Anticancer Drugs Market Size (2020-2031) & (US$ Million)
Figure 19. Global Platinum-based Anticancer Drugs Sales (2020-2031) & (MT)
Figure 20. Global Platinum-based Anticancer Drugs Average Price (US$/MT) & (2020-2031)
Figure 21. Platinum-based Anticancer Drugs Report Years Considered
Figure 22. Platinum-based Anticancer Drugs Sales Share by Manufacturers in 2024
Figure 23. Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers in 2024
Figure 24. Global 5 and 10 Largest Platinum-based Anticancer Drugs Players: Market Share by Revenue in Platinum-based Anticancer Drugs in 2024
Figure 25. Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Global Platinum-based Anticancer Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 27. North America Platinum-based Anticancer Drugs Sales Market Share by Country (2020-2031)
Figure 28. North America Platinum-based Anticancer Drugs Revenue Market Share by Country (2020-2031)
Figure 29. United States Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Canada Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Europe Platinum-based Anticancer Drugs Sales Market Share by Country (2020-2031)
Figure 32. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country (2020-2031)
Figure 33. Germany Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Russia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Platinum-based Anticancer Drugs Sales Market Share by Region (2020-2031)
Figure 39. Asia Pacific Platinum-based Anticancer Drugs Revenue Market Share by Region (2020-2031)
Figure 40. China Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. China Taiwan Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Indonesia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Thailand Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Malaysia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Platinum-based Anticancer Drugs Sales Market Share by Country (2020-2031)
Figure 50. Latin America Platinum-based Anticancer Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Platinum-based Anticancer Drugs Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Platinum-based Anticancer Drugs Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. UAE Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Platinum-based Anticancer Drugs by Type (2020-2031)
Figure 60. Global Revenue Market Share of Platinum-based Anticancer Drugs by Type (2020-2031)
Figure 61. Global Platinum-based Anticancer Drugs Price (US$/MT) by Type (2020-2031)
Figure 62. Global Sales Market Share of Platinum-based Anticancer Drugs by Application (2020-2031)
Figure 63. Global Revenue Market Share of Platinum-based Anticancer Drugs by Application (2020-2031)
Figure 64. Global Platinum-based Anticancer Drugs Price (US$/MT) by Application (2020-2031)
Figure 65. Platinum-based Anticancer Drugs Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
